Complications and cardiovascular risk factors in people with type 2 diabetes in the International Diabetes Management Practices Study (IDMPS)

CHAN J; BAIK SH; FERREIRA S; GAGLIARDINO JJ; HANCU N; ILKOVA H; RAMACHANDRAN A; TWIGG S; ASCHNER P

Washington DC

Congreso; 66th Scientific Sessions of the American Diabetes Association; 2006

American Diabetes Association

Preliminary data from the IDMPS were used to assess the frequency of chronic complications and associated cardiovascular risk factors in people with type 2 diabetes (¡Ã18 years) from 11 countries in Eastern Europe, Asia, and Latin America. This observational study enrolls patients seen in current medical practice by physicians managing diabetic patients. Data are currently available for 7543 people (48% men) with type 2 diabetes who had a mean age of 58¡¾11 years and a mean disease duration of 8 years. 11% were smokers. The mean waist circumference was 95¡¾13 cm in men and 92¡¾14 cm in women. Mean HbA¡ø1c was 7.7¡¾1.75% and 38% of people had an HbA¡ø1c <7%. 89% of people had microvascular complications (39% retinopathy, 39% nephropathy, 67% neuropathy) and 43% had macrovascular complications (30% coronary artery disease, 8% cerebrovascular disease, 14% peripheral vascular disease). Mean systolic/diastolic blood pressure (BP) was 135/81 mmHg. Antihypertensive medication was taken by 59% of people. A BP <130/80 was achieved in 20% of people. Target treatment values were achieved for LDL (<100 mg/dL) in 34% of people (46% receiving lipid lowering treatment), HDL (>40 mg/dL) in 64% of people (47% receiving lipid lowering treatment), and triglycerides (<150 mg/dL) in 48% of people (33% receiving lipid lowering treatment). Only 2% of people reached all 3 recommended targets for HbA¡ø1c, BP and lipids. Thus, although patients have wide access to medications that specifically treat these conditions, these data suggest that suitable guidance and education are necessary to ensure their effective use by people with type 2 diabetes world wide.